Experiences w/ & Attitudes Towards Immune Chckpt Inhibitors in NSCLC Patients Single Center Survey Based Study

Purpose

This study evaluates patient satisfaction with receiving intravenous (IV) and/or subcutaneous (SC) immunotherapy and to assess patient preference for IV immunotherapy administration versus SC immunotherapy administration either at the hospital or at home.

Condition

  • Lung Non-Small Cell Carcinoma

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • * Age ≥ 18 years. - * Patients must have histopathologically/cytologically confirmed non-small cell lung cancer, currently receiving Atezolizumab, Cemiplimab, Durvalumab, Nivolumab, Pembrolizumab (i.e. the patient has already received at least one cycle of therapy) - * Previous chemotherapy/radiotherapy/targeted/immunotherapy is allowed at any prior timepoint. - * Ability to understand and the willingness to sign a written informed consent or presence of a surrogate decision maker who can give consent.

Exclusion Criteria

  • * Patients is unable to consent for themselves - * Patient has not yet completed the 1st cycle of ICI-based therapy

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Observational Patients complete surveys on study.
  • Other: Non-Interventional Study
    Non-interventional study
    Other names:
    • Non-Interventional Observational Study
    • Noninterventional (Observational) Study

Recruiting Locations

Los Angeles General Medical Center
Los Angeles, California 90033
Contact:
Sandy Tran
323-865-3000
sandy.tran@med.usc.edu

USC / Norris Comprehensive Cancer Center
Los Angeles, California 90033
Contact:
Sandy Tran
323-865-3000
sandy.tran@med.usc.edu

More Details

Status
Recruiting
Sponsor
University of Southern California

Study Contact

Detailed Description

PRIMARY OBJECTIVES: I. To assess patient satisfaction with receiving IV immune checkpoint inhibitors, reflecting whether the patient thought that the experience was safe, convenient, comfortable and proceeded smoothly. II. To assess patient preference for IV versus home SC ICI administration. OUTLINE: This is an observational study. Patients complete surveys on study.